Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa).

Cournil A, Van de Perre P, Cames C, de Vincenzi I, Read JS, Luchters S, Meda N, Naidu K, Newell ML, Bork K; Kesho Bora Study Group.

Pediatr Infect Dis J. 2015 Feb;34(2):168-74. doi: 10.1097/INF.0000000000000512.

PMID:
25741969
2.

Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.

Sartorius BK, Chersich MF, Mwaura M, Meda N, Temmerman M, Newell ML, Farley TM, Luchters S; Kesho Bora Study Group.

BMC Infect Dis. 2013 Nov 6;13:522. doi: 10.1186/1471-2334-13-522.

3.

Relationship between mortality and feeding modality among children born to HIV-infected mothers in a research setting: the Kesho Bora study.

Cournil A, De Vincenzi I, Gaillard P, Cames C, Fao P, Luchters S, Rollins N, Newell ML, Bork K, Read JS; Kesho Bora Study Group.

AIDS. 2013 Jun 19;27(10):1621-30. doi: 10.1097/QAD.0b013e32835d5226.

PMID:
23262499
5.

Changes in sexual behaviour among HIV-infected women in west and east Africa in the first 24 months after delivery.

Irungu E, Chersich MF, Sanon C, Chege R, Gaillard P, Temmerman M, Read JS, Luchters S; Kesho Bora Study Group.

AIDS. 2012 May 15;26(8):997-1007. doi: 10.1097/QAD.0b013e3283524ca1.

PMID:
22343965
6.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
8.

Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso.

Viljoen J, Gampini S, Danaviah S, Valéa D, Pillay S, Kania D, Méda N, Newell ML, Van de Perre P, Rouet F; World Health Organization/ANRS 1289 Kesho Bora Study Group.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):290-8. doi: 10.1097/QAI.0b013e3181edaaf5.

PMID:
20700058
9.

Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.

Kesho Bora Study Group.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):533-41. doi: 10.1097/QAI.0b013e3181e36634.

PMID:
20543706
10.

Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.

Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso.

J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3.

11.

Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.

Rouet F, Foulongne V, Viljoen J, Steegen K, Becquart P, Valéa D, Danaviah S, Segondy M, Verhofstede C, Van de Perre P; WHO/ANRS 1289 Kesho Bora Study Group.

J Virol Methods. 2010 Feb;163(2):253-7. doi: 10.1016/j.jviromet.2009.10.005. Epub 2009 Oct 27.

PMID:
19837114

Supplemental Content

Loading ...
Support Center